Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler : a Calu-3 model
dc.contributor.author | Van Rensburg, Lyne | en_ZA |
dc.contributor.author | Van Zyl, Johann M. | en_ZA |
dc.contributor.author | Smith, Johan | en_ZA |
dc.date.accessioned | 2019-09-16T09:30:36Z | |
dc.date.available | 2019-09-16T09:30:36Z | |
dc.date.issued | 2018 | |
dc.description | CITATION: Van Rensburg, L., Van Zyl, J. M. & Smith, J. 2018. Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler : a Calu-3 model. Drug Design, Development and Therapy, 12-1107-1118, doi:10.2147/DDDT.S147035. | |
dc.description | The original publication is available at https://www.dovepress.com | |
dc.description.abstract | Background: Previous studies in our laboratory demonstrated that a synthetic peptide containing lung surfactant enhances the permeability of chemical compounds through bronchial epithelium. The purpose of this study was to test two formulations of Synsurf® combined with linezolid as respirable compounds using a pressurized metered dose inhaler (pMDI). Methods: Aerosolization efficiency of the surfactant-drug microparticles onto Calu-3 monolayers as an air interface culture was analyzed using a Next Generation Impactor™. Results: The delivered particles and drug dose showed a high dependency from the preparation that was aerosolized. Scanning electron microscopy imaging allowed for visualization of the deposited particles, establishing them as liposomal-type structures (diameter 500 nm to 2 µm) with filamentous features. Conclusion: The different surfactant drug combinations allow for an evaluation of the significance of the experimental model system, as well as assessment of the formulations providing a possible noninvasive, site-specific, delivery model via pMDI. | en_ZA |
dc.description.uri | https://www.dovepress.com/deposition-and-transport-of-linezolid-mediated-by-a-synthetic-surfacta-peer-reviewed-article-DDDT# | |
dc.description.version | Publisher's version | |
dc.format.extent | 12 pages | en_ZA |
dc.identifier.citation | Van Rensburg, L., Van Zyl, J. M. & Smith, J. 2018. Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler : a Calu-3 model. Drug Design, Development and Therapy, 12-1107-1118, doi:10.2147/DDDT.S147035 | |
dc.identifier.issn | 1177-8881 (online) | |
dc.identifier.other | doi:10.2147/DDDT.S147035 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/106476 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Dove Medical Press | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Delivery vehicle | en_ZA |
dc.subject | Pulmonary surfactant | en_ZA |
dc.subject | Aerosols | en_ZA |
dc.title | Deposition and transport of linezolid mediated by a synthetic surfactant Synsurf® within a pressurized metered dose inhaler : a Calu-3 model | en_ZA |
dc.type | Article | en_ZA |